PharmaShots

JUNE 29, 2023

The business sells nutraceutical products under categories, including Children's Health Supplements, Skin, Hair & Nails Supplements, and Immune Supplements. General Health, Immune, Cardiovascular, Digestive, Personal Care, and Weight Management are among the categories under which the company operates. Revenue: $277.2M

Immunization 40

Immunization 40

Roots Analysis

FEBRUARY 1, 2024

Cold chain is a three-fold concept, involving certain aspects that can be co-related to science, technology, and process development. In terms of science, cold chain industry requires the understanding of chemical and biological processes associated with the product.

Packaging 40

Packaging Documentation Vaccines 40

ISPE

SEPTEMBER 21, 2022

Meet the 2022 FOYA Social Impact Category Winner: Janssen Biologics. Meet the 2022 FOYA Social Impact Category Winner: Janssen Biologics. Given the unique challenges surrounding the COVID–19 pandemic, there are two projects the FOYA judges are recognizing in the category of Social Impact. Trudy Patterson. iSpeak Blog.

Vaccines 97

Vaccines Pharmaceutical Companies Pharmaceutical Companies 97

Pharmaceutical Technology

MAY 24, 2023

Every major pharma company is now involved in CGT development which has resulted in the approval of 28 therapies by the FDA thereby making CGT no longer a niche category of therapies. CGT drugs fall into two major categories: autologous and allogeneic. Differences in CGT vs traditional trials supply chain.

Labelling 98

Labelling Insurance FDA 98

The Thyroid Pharmacist

APRIL 28, 2023

Common symptoms seen in those with sarcopenia include: [5] Loss of lean muscle mass, especially in thighs and abdominal areas Weakness Reduced strength Increased risk of falling These symptoms may be exacerbated by over-exertion, exercise, or cold temperatures. The good news is that many of these are easy to implement.

Immunization 94

Immunization Dosage Compounding Communication 94

Viseven

SEPTEMBER 14, 2023

The lack of supply chain transparency The lack of supply chain visibility makes it excruciatingly challenging for pharma companies to plan medicine production, forecast demand, and manage their inventory. Any of these performance incidents may create a serious disruption at any level of the supply chain.

Packaging 52

Packaging Pharmaceutical Companies Pharmaceutical Companies Pharmacy Procurement 52

ISPE

MARCH 6, 2023

Growing public awareness and pressure, as well as technological advances coupled with CO 2 prices, are slowly changing the focus, putting the needs of our planet on the agenda. Greenhouse Gas Emissions The scopes of GHG emissions are differentiated by what stage in the value chain the GHG are emitted (see Figure 1). IEA website.

Packaging 52

Packaging Pharmaceutical Companies Pharmaceutical Companies Compounding 52